Добірка наукової літератури з теми "Antibody treatment"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Antibody treatment".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Antibody treatment"
Sasaki, Shigeru, Yasuhisa Shinomura, and Kozo Imai. "Antibody treatment." Drug Delivery System 30, no. 1 (2015): 16–24. http://dx.doi.org/10.2745/dds.30.16.
Повний текст джерелаJolobe, O. M. "Monoclonal antibody treatment." BMJ 340, apr01 2 (April 1, 2010): c1850. http://dx.doi.org/10.1136/bmj.c1850.
Повний текст джерелаLitzman, Jiří. "Treatment of antibody immunodeficiency." Vnitřní lékařství 65, no. 2 (February 1, 2019): 126–30. http://dx.doi.org/10.36290/vnl.2019.025.
Повний текст джерелаEspinoza, LR. "Antiphospholipid Antibody Syndrome: Treatment." Lupus 5, no. 5 (October 1996): 456–57. http://dx.doi.org/10.1177/096120339600500525.
Повний текст джерелаMehdi, Ali A., Imad Uthman, and Munther Khamashta. "Treatment of antiphospholipid antibody syndrome." International Journal of Clinical Rheumatology 5, no. 2 (April 2010): 241–54. http://dx.doi.org/10.2217/ijr.10.8.
Повний текст джерелаGibbons, W. "Antibody Treatment Joins AIDS Battle." Science News 139, no. 4 (January 26, 1991): 55. http://dx.doi.org/10.2307/3975553.
Повний текст джерелаLiddle, Rachel. "Antibody treatment for ovarian cancer." Lancet Oncology 8, no. 8 (August 2007): 676. http://dx.doi.org/10.1016/s1470-2045(07)70229-2.
Повний текст джерелаVexler, Vladimir, and Jacky Woo. "Antibody treatment of ulcerative colitis." Drug Discovery Today: Therapeutic Strategies 3, no. 3 (September 2006): 353–60. http://dx.doi.org/10.1016/j.ddstr.2006.07.002.
Повний текст джерелаWahl, Denis, and Veronique Regnault. "Treatment of Antiphospholipid Antibody Syndrome." JAMA 296, no. 1 (July 5, 2006): 42. http://dx.doi.org/10.1001/jama.296.1.42.
Повний текст джерелаGardulf, Ann. "Immunoglobulin Treatment for Primary Antibody Deficiencies." BioDrugs 21, no. 2 (2007): 105–16. http://dx.doi.org/10.2165/00063030-200721020-00005.
Повний текст джерелаДисертації з теми "Antibody treatment"
Alsughayyir, Jawaher. "CD49d-specific Single Domain Antibodies for the Treatment of Multiple Sclerosis." Thesis, Université d'Ottawa / University of Ottawa, 2012. http://hdl.handle.net/10393/23528.
Повний текст джерелаChen, Chao, and 陳超. "Identification of a novel cancer therapeutic antibody against human epidermal growth factor receptor 2 (Her2) and antibody engineering for development of cancer therapeutics." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/196461.
Повний текст джерелаpublished_or_final_version
Microbiology
Doctoral
Doctor of Philosophy
Schroeder, Krista Marie. "Disparities in Monoclonal Antibody Treatment of Elderly Metastatic Colorectal Cancer Patients." ScholarWorks, 2015. https://scholarworks.waldenu.edu/dissertations/1421.
Повний текст джерелаOdili, Joy Ifeyinewa. "Development of specific antibody fragments for the detection and treatment of melanoma." Thesis, University College London (University of London), 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.430128.
Повний текст джерелаAlberts, Justin Charles John. "Bispecific antibody mediated targeting cytotoxic lymphocytes for the treatment of colorectal carcinoma." Thesis, University College London (University of London), 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.248396.
Повний текст джерелаDouglass, Angela. "The use of an antibody in the diagnosis and treatment of liver fibrosis." Thesis, University of Aberdeen, 2009. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=131533.
Повний текст джерелаDI, CINTIO FEDERICA. "Nanoparticles anti-GPC1 for glioblastoma multiforme treatment." Doctoral thesis, Università degli Studi di Trieste, 2022. http://hdl.handle.net/11368/3015204.
Повний текст джерелаGlioblastoma multiforme (GBM) the most aggressive (WHO grade IV) diffuse glioma, is also by far the most frequent one. After standard treatment, the 2-year overall survival of GBM patients is approximately only 25%. Although numerous experimental drugs have been tested in clinical trials, GBM patients have not yet profited of curative treatments. To overcome the big limitations regarding GBM treatment, we address the challenge of developing a drug delivery system based on highly biocompatible chitosan nanobubbles (NBs) conjugated with an anti-glypican1 (GPC1) antibody loaded with docetaxel as chemotherapeutic agent. This drug delivery approach has been proposed to counter major challenges as overcoming the BBB, allowing the therapeutic release exclusively to tumor cells, and minimizing the possible side effects in cancer patients. The GPC1 proteoglycan has been chosen as useful target for drug delivering with NBs, therefore GPC1 expression was characterized in-vitro, being found expressed in GBM cell lines (e.g., T98G, U87-MG) but not found expressed in non-GBM cell line. Consistently, we assessed the localization of GPC1 protein expression on the cell surface and in the cytoplasm of GBM cell lines whereas it was lacked in the negative control cells. Of note, in primary tumor sections of these 10 GBM cases, GPC1 was found overexpressed whereas in normal tissues was found not expressed. To obtain a specific anti-GPC1 antibody recognizing the last 70 amino acid of GPC1 protein and therefore the cell-surface form of GPC1, mouse immunization has been performed. Hybridomas have produced three different anti-GPC1 specific clones (A, B, C). By using the B and C clones, GPC1 expression was detected in GBM cells at levels comparable to the levels obtained by using the commercially available antibody by the B and C clones. On the contrary, the A clone was not capable to recognize GPC1. Therefore, we purified the B and C clones to obtain specific anti-GPC1 monoclonal Abs. Moreover, C and B appeared to be more efficient than the a-GPC1c for detection of GPC1 expression levels. According to the results of antibody testing in GBM cell lines and negative control cell lines, the B clone was chosen to be conjugated to the NBs to develop the active drug delivery strategy. To select the drug to be loaded in the NBs, the killing capability of temozolomide (TMZ), paclitaxel (PTX) and docetaxel (DTX) was evaluated in GBM cells. DTX have the highest killing capability compared to PTX and TMZ. Therefore, we used DTX for the NBs loading encapsulation. The in-vitro characterization of NBs showed the average diameter of about 350 nm and a positive charge and spherical morphology. In-vitro analysis of the treatment of NBs in GBM cells, showed the localization of NBs conjugated with B antibody in cell cytoplasm around the nucleus. In contrast, a lower mean fluorescence intensity was observed for the cells treated with unconjugated NBs. For the in-vitro cytotoxic effect of NBs, NB loaded with DTX, NBs loaded with DTX and conjugated with B antibody, showed a killing capability correlated with the concentration in each evaluated point, with cell viable levels comparable to those of free DTX for some concentrations. Blank NBs, NB conjugated with Cy 5.5, and NB conjugated with B antibody were not toxic at all tested concentrations. In-vivo and ex-vivo test of the biodistribution of anti-GPC1 NBs in xenograft GBM mouse models, showed that the presence of the conjugation with the B antibody seems to be allow a major accumulation of the injected NBs in the tumor as well as a higher retention time at least until the last time point of 96 h of treatment. In conclusion, the proposed active drug delivery approach using anti-GPC1 conjugated NBs loaded with DTX could be useful for the treatment of GBM.
Arrowood, Michael James. "Cryptosporidium: Oocyst production and hybridoma generation for examining colostrum and monoclonal antibody roles in cryptosporidial infections." Diss., The University of Arizona, 1988. http://hdl.handle.net/10150/184335.
Повний текст джерелаLopez-Oliva, Santa Cruz Isabel. "Rheumatoid arthritis and periodontitis : antibody response, oral microbiome, cytokine profile and effect of periodontal treatment." Thesis, University of Birmingham, 2018. http://etheses.bham.ac.uk//id/eprint/8058/.
Повний текст джерелаLocker, Kathryn CS. "Molecular mechanisms underlying treatment of acute type 1 diabetes with an anti-TLR4/MD2 antibody." University of Cincinnati / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1601993060493285.
Повний текст джерелаКниги з теми "Antibody treatment"
K, Dessain Scott, ed. Human antibody therapeutics for viral disease. Berlin: Springer Verlag, 2008.
Знайти повний текст джерела1960-, Grossbard Michael L., ed. Monoclonal antibody-based therapy of cancer. New York: Dekker, 1998.
Знайти повний текст джерелаA, Foon Kenneth, and Morgan Alton C, eds. Monoclonal antibody therapy of human cancer. Boston: Nijhoff, 1985.
Знайти повний текст джерелаW, Baldwin R., Byers Vera S, and Mann R. D. 1928-, eds. Monoclonal antibodies and immunoconjugates in cancer treatment. Carnforth: Parthenon Publishing, 1990.
Знайти повний текст джерелаCeriani, Roberto L., ed. Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2443-4.
Повний текст джерелаL, Ceriani Roberto, and International Workshop on Breast Cancer Research (5th : 1992 : San Francisco, Calif.), eds. Antigen and antibody molecular engineering in breast cancer diagnosis and treatment. New York: Plenum Press, 1994.
Знайти повний текст джерелаE, Frankel Arthur, ed. Immunotoxins. Boston: Kluwer Academic Publishers, 1988.
Знайти повний текст джерела1927-, Baldwin R. W., Byers Vera S, and Mann Ronald D. 1928-, eds. Monoclonal antibodies and immunoconjugates. Carnforth, Lancs, UK: Parthenon Pub. Group, 1990.
Знайти повний текст джерелаG, Melton Roger, and Knox Richard J, eds. Enzyme-prodrug strategies for cancer therapy. New York: Kluwer Academic/Plenum Publishers, 1999.
Знайти повний текст джерелаOehlrich, Marcus. Recombinant monoclonal antibody trastuzumab for the treatment of metastatic breast cancer with tumors overexpressing the HER2-neu proto-oncogene: A systematic review. Berlin: dissertation.de, 2003.
Знайти повний текст джерелаЧастини книг з теми "Antibody treatment"
Acaia, Barbara, Federica Rossi, and Cecilia Beatrice Chighizola. "Treatment of Pregnancy Complications." In Antiphospholipid Antibody Syndrome, 193–206. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-11044-8_16.
Повний текст джерелаBraham, Simon, Paolo Bucciarelli, and Marco Moia. "Treatment of Thrombosis in Antiphospholipid Syndrome." In Antiphospholipid Antibody Syndrome, 185–92. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-11044-8_15.
Повний текст джерелаPress, Oliver W., Janet Eary, Frederick R. Appelbaum, Christopher C. Badger, and Irwin D. Bernstein. "Radiolabeled antibody therapy of lymphoma." In Cancer Treatment and Research, 127–45. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-3084-8_9.
Повний текст джерелаSanz, Ana Rodríguez, Melissa Báez Martínez, Ángel Robles Marhuenda, and Patricia Martínez-Sánchez. "Antiphospholipid Antibody Syndrome." In Stroke Revisited: Diagnosis and Treatment of Ischemic Stroke, 199–206. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-1424-6_18.
Повний текст джерелаOosterwijk, Egbert, Adrienne Brouwers, OTTO C. Boerman, Steven M. Larson, Lloyd J. Old, Peter Mulders, and Chaitanya R. Divgi. "Monoclonal Antibody Therapy of Kidney Cancer." In Cancer Treatment and Research, 199–212. Boston, MA: Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0451-1_12.
Повний текст джерелаWhelan, Glenn J. "Monoclonal Antibodies in the Treatment of Asthma." In Antibody-Mediated Drug Delivery Systems, 457–72. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2012. http://dx.doi.org/10.1002/9781118229019.ch22.
Повний текст джерелаBhattacharya-Chatterjee, Malaya, and Kenneth A. Foon. "Anti-idiotype antibody vaccine therapies of cancer." In Cancer Treatment and Research, 51–68. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-6189-7_4.
Повний текст джерелаVahdat, Linda T., and Nancy Chan. "The Antibody-Drug Conjugate Glembatumumab Vedotin (CDX-011) and Its Use in Treatment of Breast Cancer." In Antibody-Drug Conjugates, 225–32. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13081-1_13.
Повний текст джерелаDeng, Rong, and Joseph P. Balthasar. "Immune Complex Therapies for Treatment of Immune Thrombocytopenia." In Development of Antibody-Based Therapeutics, 391–404. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-5955-3_17.
Повний текст джерелаKumar, Dhruv, Neelam Sharma-Walia, Sonia Kapoor, and Simran Tandon. "Antibody-Targeted Nanoparticles for Cancer Treatment." In NanoBioMedicine, 35–65. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-32-9898-9_3.
Повний текст джерелаТези доповідей конференцій з теми "Antibody treatment"
Song, Muran. "The application of monoclonal antibody immunotherapy in cancer treatment." In International Conference on Biological Engineering and Medical Science (ICBIOMed2022), edited by Gary Royle and Steven M. Lipkin. SPIE, 2023. http://dx.doi.org/10.1117/12.2669347.
Повний текст джерелаPrudent, James R., David Marshall, John Murphy, Chad Hall, and Scott Harried. "Abstract A125: Antibody targeted steroids for the treatment of cancer." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5-9, 2015; Boston, MA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1535-7163.targ-15-a125.
Повний текст джерелаHerbert, Jenny, and Timothy Mitchell. "Development of an antibody therapy for the treatment of pneumonia." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa2623.
Повний текст джерелаXu, Minglu. "Progress and perspectives of antibody-drug conjugates in cancer treatment." In International Conference on Biological Engineering and Medical Science (ICBIOMed2022), edited by Gary Royle and Steven M. Lipkin. SPIE, 2023. http://dx.doi.org/10.1117/12.2669936.
Повний текст джерелаWillis, Jace A., Vsevolod Cheburkanov, Giulia Kassab, Vanderlei S. Bagnato, and Vladislav V. Yakovlev. "MHV-1 in vivo viral load reduction via antibody-conjugated photodynamic inactivation." In Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2021, edited by Tianhong Dai, Mei X. Wu, and Jürgen Popp. SPIE, 2021. http://dx.doi.org/10.1117/12.2577893.
Повний текст джерелаParapia, L., A. Minford, and J. B. Hamilton. "MONOCLONAL PURIFIED FACTOR VIII:C (MONOCLATE) TREATMENT IN A PREVIOUSLY UNTREATED HAEMOPHILIA." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644846.
Повний текст джерелаIshiguro, Takahiro, Yasuko Kinoshita, Masamichi Sugimoto, Yoko Miyazaki, Atsuhiko Kato, Kiyotaka Nakano, Hirotake Takai, et al. "Abstract 2426: Anti-Glypican3 antibody for treatment of human liver cancer." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2426.
Повний текст джерелаGiffin, Michael J., Ed K. Lobenhofer, Keegan Cooke, Tobias Raum, Jennitte Stevens, Pedro J. Beltran, Angela Coxon, and Paul E. Hughes. "Abstract 3632: BiTE®antibody constructs for the treatment of SCLC." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-3632.
Повний текст джерелаSchmittnaegel, Martina, Eike Hoffmann, Olaf Mundigl, Gerhard Niederfellner, Klaus Bosslet, Pablo Umana, Victor Levitsky, Christian Klein, and Hendrik Knoetgen. "Abstract B69: Novel MHC class I antibody fusions for cancer treatment." In Abstracts: AACR Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances; December 2-5, 2012; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tumimm2012-b69.
Повний текст джерелаNilsson, I. M., E. Berntorp, and O. Zettervall. "TOLERANCE INDUCTION IN HIGH-RESPONDING HEMOPHILIACS WITH F VIII ANTIBODIES BY MEANS OF COMBINED TREATMENT WITH IgG, CYCLOPHOSPHAMIDE AND F VIII." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644717.
Повний текст джерелаЗвіти організацій з теми "Antibody treatment"
Sholler, Giselle. Marrow-Derived Antibody Library for Treatment of Neuroblastoma. Fort Belvoir, VA: Defense Technical Information Center, September 2013. http://dx.doi.org/10.21236/ada593124.
Повний текст джерелаBasu, Sayani. Monoclonal Antibody Therapy: A New Hope in Cancer Treatment. Natur Library, November 2020. http://dx.doi.org/10.47496/nl.blog.14.
Повний текст джерелаWu, Xin. The efficacy and safety of anti-CD20 antibody treatments in relapsing multiple sclerosis: a systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2022. http://dx.doi.org/10.37766/inplasy2022.6.0075.
Повний текст джерелаLiu, Miao, Hongan Wang, Jing Lu, Zhiyue Zhu, Chaoqun Song, Ye Tian, Xinzhi Chen, et al. Vitamin D supplementation in the treatment of Myasthenia Gravis A protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0129.
Повний текст джерелаBray, Elizabeth, Zvi Lerner, and Alexander Poljakoff-Mayber. The Role of Phytohormones in the Response of Plants to Salinity Stress. United States Department of Agriculture, September 1994. http://dx.doi.org/10.32747/1994.7613007.bard.
Повний текст джерелаSpiegel, Yitzhak, Michael McClure, Itzhak Kahane, and B. M. Zuckerman. Characterization of the Phytophagous Nematode Surface Coat to Provide New Strategies for Biocontrol. United States Department of Agriculture, November 1995. http://dx.doi.org/10.32747/1995.7613015.bard.
Повний текст джерелаSchwartz, Bertha, Vaclav Vetvicka, Ofer Danai, and Yitzhak Hadar. Increasing the value of mushrooms as functional foods: induction of alpha and beta glucan content via novel cultivation methods. United States Department of Agriculture, January 2015. http://dx.doi.org/10.32747/2015.7600033.bard.
Повний текст джерелаCahaner, Avigdor, Susan J. Lamont, E. Dan Heller, and Jossi Hillel. Molecular Genetic Dissection of Complex Immunocompetence Traits in Broilers. United States Department of Agriculture, August 2003. http://dx.doi.org/10.32747/2003.7586461.bard.
Повний текст джерела